SHI
SV Health Investors Portfolio holdings
AUM $32.3M
1-Year Return
20.15%
This Quarter Return
+48.22%
1 Year Return
-20.15%
3 Year Return
+90.94%
5 Year Return
+318.05%
10 Year Return
–
AUM
$218M
AUM Growth
+$84.5M
(+63%)
Cap. Flow
+$72.8M
Cap. Flow
% of AUM
33.42%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
+$78.1M |
| 2 |
ETRM
EnteroMedics Inc.
ETRM
|
+$346K |
Top Sells
| 1 |
RSLS
ReShape Lifesciences Inc. Common Stock
RSLS
|
+$3.26M |
| 2 |
Ocular Therapeutix
OCUL
|
+$2.43M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
1
Tectonic Therapeutic, Inc. Common Stock
TECX
$310M
| $78.1M | 35.88% |
+228,002
| New | +$78.1M |
|
|
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $67.5M | 31.01% |
1,716,303
| – | – |
|
|
ASXC
3
DELISTED
Asensus Surgical, Inc.
ASXC
| $32.9M | 15.11% |
580,515
| – | – |
|
4
KalVista Pharmaceuticals
KALV
$688M
| $20.9M | 9.62% |
2,579,490
| – | – |
|
|
5
Ocular Therapeutix
OCUL
$2.18B
| $8.41M | 3.86% |
1,245,270
-359,937
| -22% | -$2.43M |
|
6
X4 Pharmaceuticals
XFOR
$67.1M
| $6.79M | 3.12% |
10,383
| – | – |
|
7
Astria Therapeutics
ATXS
$416M
| $2.74M | 1.26% |
47,628
| – | – |
|
|
ETRM
8
DELISTED
EnteroMedics Inc.
ETRM
| $346K | 0.16% |
+150,064
| New | +$346K |
|
|
RSLS
9
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
| – | – |
-1,072
| Closed | -$3.26M |
|